PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
May 2, 2024Cancer Research

Abstract PO3-03-11: Receptor discordance after neoadjuvant chemotherapy with pembrolizumab in early-stage triple-negative breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

ALAlexis LeVeeMWMegan WongSFSarah Flores

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

LeVee et al. (2024) studied this question.

synapsesocial.com/papers/68e6be8eb6db64358763e3e8https://doi.org/10.1158/1538-7445.sabcs23-po3-03-11
View Full Paper
Ask AI
Bookmark
Share